-
Moderna Inc. requests authorization for COVID-19 vaccine Moderna Inc. requests authorization of emergency use for the coronavirus (COVID-19) vaccine with regulators in the U.S. and Europe. This request follows the exciting and promising results... -
Moderna Inc. announces successful study for COVID-19 vaccine Moderna Inc. released the latest data from its late-stage trial for its experimental coronavirus (COVID-19) vaccine, mRNA-1273, proving to be 94.5% effective in preventing COVID-19 infection....
